PIERRE FABRE MEDICAL DEVICES – Pharmacyapozona
PIERRE FABRE – ApoZona
Pierre Fabre to commercialize Aprotecol in Italy
Pierre Fabre
Acting alongside patients: a Pierre Fabre Group commitment
Pierre Fabre KLORANE Bébé Hydrating Milk 500 ml
BiomunilPlus Children Pierre Fabre Pharma - Loreto Pharmacy
Pierre Fabre USA (ADA)
The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment for XLHED, a dermatologic-related rare genetic disease that requires prenatal therapeutic intervention
Pierre Fabre is taking a minority stake in Gennisium Pharma
Pierre Fabre Offre Bébé Multimarque : 2 achetés = -10% / 3 achetés = -15% / 4 achetés = -25% - Parapharmacie Boticinal
Glycerol Vaseline Paraffin, Pierre Fabre Santé, 15% / 8% / 2% – Damode USA
Pierre Fabre Healthcare – Chanh thi
Pierre Fabre, Made in France all over the world
News
Noventure and Pierre Fabre enter into an agreement to commercialise Aprotecol® in Italy
Partners of the Pierre Fabre Group: from health to beauty
Pierre Fabre - The Dosing and Administration of HEMANGEOL
EspeRare Partners with Pierre Fabre to Develop Treatment for XLHED - NFED
Pierre Fabre working with dermatologists to fight melanoma | Pierre Fabre
Pierre Fabre is taking a minority stake, via its dedicated investment subsidiary Pierre Fabre Invest, in Gennisium Pharma, an innovative company specializing in medicines for premature newborns and niche markets
